M A Franke
Overview
Explore the profile of M A Franke including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
116
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Franke M, Truss L, Wierenga H, Nordmann K, Fruhauf A, Ranaivoson R, et al.
Public Health Action
. 2022 Dec;
12(4):174-179.
PMID: 36561910
Background: Knowledge about factors influencing access and adherence to TB care, and on the impact of the COVID-19 pandemic on TB care in resource-restricted settings is scarce. We conducted this...
2.
Young J, Orosz I, Franke M, Kim H, Woodworth D, Ellingson B, et al.
Clin Radiol
. 2017 Dec;
73(3):290-295.
PMID: 29208312
Aim: To determine whether repeated gadolinium-based contrast agent administration (GBCA) in children is associated with the development of increased T1-weighted signal intensity within the cerebellar dentate nucleus. Materials And Methods:...
3.
Baltch A, Smith R, Franke M, Ritz W, MICHELSEN P, Bopp L
Antimicrob Agents Chemother
. 2000 Dec;
45(1):96-104.
PMID: 11120951
This study evaluates the effects of cytokines, used singly and in combination, on the microbicidal activity of human monocyte-derived macrophages (MDM) against intracellular Candida albicans in the presence and absence...
4.
Baltch A, Smith R, Ritz W, Franke M, MICHELSEN P
J Antimicrob Chemother
. 2000 Jul;
46(1):51-5.
PMID: 10882688
The activity of the ketolide telithromycin (HMR 3647) against intracellular Legionella pneumophila strain L-1033 was compared with the activities of erythromycin and levofloxacin. To assay intracellular antibacterial activity, human monocytes...
5.
Baltch A, Smith R, Franke M, Ritz W, Michelsen P, Bopp L, et al.
Am J Infect Control
. 2000 Jun;
28(3):251-7.
PMID: 10840346
Background: MDI-P (Medical Discoveries, Inc-Pharmaceutical, Layton, Utah) is a clear, colorless liquid generated by electrolysis of preservative-free and endotoxin-free, nonpyrogenic, sterile, injection saline (0.9% NaCl, wt/vol). It contains numerous highly...
6.
Smith R, Baltch A, Franke M, MICHELSEN P, Bopp L
J Antimicrob Chemother
. 2000 Apr;
45(4):483-8.
PMID: 10747825
Intracellular bacteria often cause relapsing and refractory infections. However, these infections can be treated effectively with antibiotics such as ofloxacin which penetrate into the cells containing bacteria. As levofloxacin, the...
7.
Baltch A, Smith R, Franke M, MICHELSEN P
Antimicrob Agents Chemother
. 1998 Dec;
42(12):3153-6.
PMID: 9835507
The antibacterial activities of levofloxacin, erythromycin, and rifampin against intracellular Legionella pneumophila L-1033, serogroup 1, were studied. In an in vitro system utilizing adherent human monocytes, L. pneumophila L-1033, a...
8.
Louie A, Baltch A, Franke M, Ritz W, Smith R, Singh J, et al.
J Antimicrob Chemother
. 1996 May;
37(5):943-54.
PMID: 8737144
Pentoxifylline can decrease the production of tumour necrosis factor alpha (TNF alpha) by endotoxin-stimulated macrophages and may improve survival in animals with overwhelming bacterial sepsis. In this study various doses...
9.
Louie A, Baltch A, Smith R, Franke M, Ritz W, Singh J, et al.
J Infect Dis
. 1995 Feb;
171(2):406-15.
PMID: 7844378
In systemic candidiasis, endogenously produced tumor necrosis factor (TNF)-alpha prolongs survival of the infected host. To determine whether endogenously produced TNF-alpha has a beneficial effect beyond that provided by antifungal...
10.
Louie A, Baltch A, Franke M, Smith R, Gordon M
J Antimicrob Chemother
. 1994 Dec;
34(6):975-87.
PMID: 7730240
The efficacy and toxicity of certain antifungal agents may be related to their ability to induce the production of cytokines by mononuclear phagocytes. The capacity of incremental concentrations of fluconazole,...